CINCINNATI—The University of Cincinnati Heart, Lung and Vascular Institute (HLVI) has made seven additions to its team of heart surgeons and researchers to strengthen heart health for residents of the Tristate and beyond.
Charles Hattemer, MD, professor of medicine in the Division of Cardiovascular Health and Disease, is an interventional cardiologist who sees patients at the UC Health Physicians Office-Clifton. He received his medical degree from Case Western Reserve University School of Medicine and did his internship, residency and chief residency at University of Cincinnati Medical Center.
Hattemer was on faculty at UC for eight years in the 1990s and won the Richard Vilter Faculty Teaching Award twice. He recently served as director of cardiology and director of the cardiac catheterization lab for eight years at Christ Hospital in Cincinnati and two years as director of the cardiac catheterization lab at Mercy Hospital Anderson in suburban Cincinnati before returning to UC last fall. At UC, he is associate chief for clinical affairs for the Division of Cardiovascular Health and Disease.
"Returning to UC is an opportunity to join a team that is thoroughly committed to superb cardiac care. We will provide effective, state of the art, and compassionate care for our patients,” said Hattemer. "My personal mission is to find ways to help our team at UC reach new levels of excellence.”
The UC Heart, Lung and Vascular Institute is a partnership between UC Health and the University of Cincinnati College of Medicine designed to connect expert physicians with cutting- edge researchers to make breakthroughs in medicine. Important additions to the HLVI also include: David Feldman, MD, PhD; Louis B. Louis IV, MD; Dylan Steen, MD; Timothy Smith, MD; Satya Shreenivas, MD; and Phillip Owens, PhD.
David Feldman, MD, professor of medicine in the Division of Cardiovascular Health and Disease, is director of clinical services and director of advanced myocardial and circulatory services for HLVI. He comes to UC from Abbott Northwestern Hospital in Minneapolis, where he was vice chairman of cardiology and director of heart failure, ventricular assist devices and cardiac transplantation. He is a former faculty member at Ohio State University College of Medicine. Feldman completed his residency and a medicine and cardiology fellowship at Washington University School of Medicine in St. Louis, and a molecular and cell biology fellowship at Duke University Medical Center in Durham, North Carolina. In addition to his clinical skills, Feldman also will contribute significantly to the Institute’s science mission.
Louis B. Louis IV, MD, associate professor of surgery and chief of cardiac surgery, sees patients in the UC Health Advanced Heart Failure Treatment Center at the Hoxworth Center in Clifton. He is a past faculty member at UC. Louis returns to UC from Abbott Northwestern Hospital in Minneapolis, where he was surgical director of cardiac transplantation and mechanical circulatory support.
Dylan Steen, MD, assistant professor medicine, directs HLVI clinical trials and a population-based research for the Division of Cardiovascular Health and Disease, designed to advance patient care and health delivery through clinical research and innovative technologies and treatment strategies. His research will look at understanding the risk factors driving the epidemics of obesity, diabetes, hypertension and coronary heart disease as well as disparities among patient populations. Steen recently completed a clinical research fellowship at Harvard Medical School and Brigham and Women’s Hospital. He holds a master of science in epidemiology at Harvard School of Public Health. Steen completed his residency in internal medicine and fellowship in cardiology at Jackson Memorial Hospital in Miami, Florida.
Timothy Smith, MD, assistant professor in the Division of Cardiovascular Health and Disease, is an interventional cardiologist who was recruited to UC to direct the Cardiovascular Intensive Care Unit. He sees patients at UC Health Physician’s Office-Clifton. Smith received his medical degree from East Carolina University in Greenville, North Carolina. He completed an internal medicine residency at the Carolinas Medical Center, University of North Carolina campus in Charlotte, North Carolina, and completed fellowships in interventional cardiology, cardiovascular disease and critical care medicine at Rush University Medical Center in Chicago.
Satya Shreenivas, MD, assistant professor in the Division of Cardiovascular Health and Disease, was recruited from the University of Pennsylvania and now oversees the HLVI structural heart disease program tasked with implanting new heart valves non-surgically through the use of transcatheter aortic valve replacement (TAVR) and repairing heart valves (also non-surgically). He received his medical degree from the University of Alabama at Birmingham and completed a residency, internship and two fellowships at the University of Pennsylvania in Philadelphia.
Phillip Owens, PhD, assistant professor in the Division of Cardiovascular Health and Disease, is a highly skilled National Institutes of Health-funded translational scientist. His research focuses on the molecular mechanisms of human vascular diseases, including atherosclerosis and abdominal aortic aneurysms. Owens received his doctoral degree in toxicology from the University of Kentucky and completed postdoctoral studies in thrombosis and hemostasis at the University of North Carolina at Chapel Hill.
Richard Becker, MD, director and physician-in-chief of HLVI, says the new hires will advance the institute’s mission of providing superb patient care, cutting edge basic science and clinical research and unparalleled education and training in the cardiovascular field.
"These are all the highly skilled, well-trained people who will take us one step closer to having our vision realized,” says Becker. "They add new dimensions to our existing faculty known for their commitment to optimal patient care and align perfectly with several contemporary centers of excellence. There is strategic diversity within the group, where each has been trained at the best academic institutions in their respective specialty areas, but collectively they represent the HLVI and all that it strives to achieve for our community, science and medicine.”